Niloofar Afari Selected Research

Niloofar Afari Research Topics

9	Pain (Aches) 01/2022 - 03/2010
7	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2021 - 01/2009
2	Obesity 05/2022 - 05/2021
2	Overweight 05/2022 - 05/2021
2	Chronic Pain 01/2022 - 10/2011
2	Wounds and Injuries (Trauma) 01/2022 - 01/2021
2	Bulimia (Binge Eating) 05/2021 - 04/2015
1	Hypertension (High Blood Pressure) 05/2022
1	Syndrome (Syndromes) 12/2020
1	Chronic Disease (Chronic Diseases) 02/2016
1	Hyperphagia (Overeating) 04/2015
1	Fibromyalgia (Fibrositis) 01/2012
1	Inflammation (Inflammations) 10/2011
1	Fatigue 03/2010
1	Sleepiness 03/2010
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2009

3	Biological ProductsIBA 05/2021 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2011
2	Triglycerides (Triacylglycerol)IBA 05/2022 - 01/2009
2	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2022 - 12/2020
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2017 - 03/2015
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017 - 04/2014
1	CholesterolIBA 05/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	BESIBA 05/2021
1	mesoglycanIBA 04/2017
1	GlucocorticoidsIBA 04/2017
1	Serotonin (5 Hydroxytryptamine)IBA 04/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Asu(1,6)- argipressin (VAS-A)IBA 01/2016
1	T-82 (T 82)IBA 01/2012
1	C-Reactive ProteinIBA 10/2011
1	Oxygen (Dioxygen)IBA 03/2010
1	Glucose (Dextrose)FDA LinkGeneric 01/2009
1	Biological FactorsIBA 01/2009
1	HDL LipoproteinsIBA 01/2009
1	HDL CholesterolIBA 01/2009
1	Nicotine FDA Link 01/2009